Development and Validation of a Nomogram to Predict Recurrence of Primary Hyperhidrosis after CT-guided Percutaneous Radiofrequency Sympathectomy

医学 列线图 危险系数 置信区间 多汗症 回顾性队列研究 经皮 比例危险模型 放射科 外科 内科学
作者
Zixin Han,Rui Min,Zhiqiang Zhang,Jiayi Tang,Longsheng Xu,Ming Yao
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier BV]
卷期号:34 (11): 1892-1900.e4 被引量:1
标识
DOI:10.1016/j.jvir.2023.07.030
摘要

To evaluate the recurrence rate of primary hyperhidrosis (PH) after computed tomography (CT)-guided radiofrequency sympathectomy (RFS) and identify risk factors associated with recurrence.A total of 290 patients with PH who underwent CT-guided RFS were included in this retrospective cohort study. The electronic medical record was reviewed for patients' information and procedural parameters. Follow-ups were conducted for recurrence rate, and Hyperhidrosis Disease Severity Scale was used to assess presence or absence of recurrence. Stepwise regression and the least absolute shrinkage and selection operator regression algorithms were used for feature selection.The recurrence rate 1 year after procedure was 17.6%. Male (hazard ratio [HR], 2.35; 95% confidence interval [CI], 1.08-5.15), low postoperative palm or foot temperature (HR, 0.77; 95% CI, 0.60-0.98), high postoperative heart rate (HR, 1.06; 95% CI, 1.02-1.10), low preoperative and postoperative hospital anxiety and depression score difference (HR, 0.59; 95% CI, 0.43-0.80), and the absence of compensatory hyperhidrosis immediately after procedure (HR, 0.46; 95% CI, 0.22-0.98) were established as independent factors affecting prognosis. A nomogram was built accordingly. The C indices of the training and testing sets were 0.773 and 0.659, respectively.Follow-up results showed that the recurrence rate of PH treated with CT-guided RFS was low. This study constructed and validated a nomogram to predict the recurrence of PH 1 year after CT-guided RFS, which is convenient for interventionalists to evaluate accurately the prognosis of patients postoperatively and to identify high-risk patients who need more active treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
平淡访冬完成签到 ,获得积分10
刚刚
科研通AI2S应助芋泥采纳,获得10
1秒前
Hello应助虚心的冷雪采纳,获得10
1秒前
mayberichard发布了新的文献求助10
1秒前
xixixi完成签到,获得积分10
1秒前
yznfly应助willsong采纳,获得50
1秒前
2秒前
mzone完成签到,获得积分10
2秒前
2秒前
绿洲完成签到,获得积分10
3秒前
4秒前
pluto应助叶子采纳,获得10
4秒前
5秒前
tt完成签到,获得积分10
5秒前
Jasper应助大气海露采纳,获得10
5秒前
6秒前
6秒前
核桃应助XXXp采纳,获得10
7秒前
柠觉呢发布了新的文献求助30
8秒前
嘘嘘发布了新的文献求助10
10秒前
危机的囧完成签到,获得积分10
10秒前
10秒前
烟花应助cang采纳,获得10
11秒前
12秒前
13秒前
平淡雪枫完成签到 ,获得积分10
14秒前
千跃给yisen的求助进行了留言
14秒前
18秒前
QYPANG发布了新的文献求助10
18秒前
wwwwww完成签到,获得积分10
18秒前
19秒前
li发布了新的文献求助10
19秒前
YZ发布了新的文献求助10
19秒前
hujun完成签到 ,获得积分10
20秒前
20秒前
23秒前
23秒前
陈澄橙完成签到,获得积分10
24秒前
传奇3应助超速也文章采纳,获得10
24秒前
wwwwww发布了新的文献求助10
25秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
不知道标题是什么 500
Christian Women in Chinese Society: The Anglican Story 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3962070
求助须知:如何正确求助?哪些是违规求助? 3508372
关于积分的说明 11140413
捐赠科研通 3240967
什么是DOI,文献DOI怎么找? 1791157
邀请新用户注册赠送积分活动 872793
科研通“疑难数据库(出版商)”最低求助积分说明 803371